Free Trial
NASDAQ:SLXN

Silexion Therapeutics (SLXN) Stock Price, News & Analysis

Silexion Therapeutics logo
$1.17 -0.01 (-0.85%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$1.18 +0.02 (+1.28%)
As of 03/28/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Silexion Therapeutics Stock (NASDAQ:SLXN)

Key Stats

Today's Range
$1.11
$1.19
50-Day Range
$0.58
$3.14
52-Week Range
$0.58
$41.85
Volume
256,498 shs
Average Volume
5.99 million shs
Market Capitalization
$9.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Buy

Company Overview

Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.

Remove Ads
Receive SLXN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silexion Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SLXN Stock News Headlines

Silexion Therapeutics announces expanded development plan for SIL204
Trump’s Great Society
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Silexion announces completion of expanded development plan for SIL204
Silexion Therapeutics price target lowered to $5 from $9 at Maxim
See More Headlines

SLXN Stock Analysis - Frequently Asked Questions

Silexion Therapeutics' stock was trading at $2.01 on January 1st, 2025. Since then, SLXN shares have decreased by 41.8% and is now trading at $1.17.
View the best growth stocks for 2025 here
.

Shares of Silexion Therapeutics reverse split before market open on Friday, November 29th 2024. The 1-9 reverse split was announced on Saturday, January 1st 2000. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 28th 2024. An investor that had 100 shares of stock prior to the reverse split would have 11 shares after the split.

Silexion Therapeutics' top institutional investors include Wildcat Capital Management LLC (7.09%).

Shares of SLXN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Silexion Therapeutics investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

Today
3/28/2025
Next Earnings (Estimated)
5/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SLXN
Previous Symbol
NASDAQ:SLXN
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.00
High Stock Price Target
$5.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+327.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$260,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.80 per share
Price / Cash Flow
1.46
Book Value
($6.63) per share
Price / Book
-0.18

Miscellaneous

Free Float
1,074,000
Market Cap
$9.85 million
Optionable
N/A
Beta
0.11
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:SLXN) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners